N 812
Alternative Names: N-812Latest Information Update: 06 May 2024
At a glance
- Originator ImmunityBio
- Class Antineoplastics; Immunotherapies; Recombinant fusion proteins
- Mechanism of Action Interleukin 12 modulators; Tumour necrosis factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours